The Lathell B2B Platform provides institutional access to SAFE SUGAR™ and advanced nutraceutical technologies through bulk supply, licensing, manufacturing partnerships, and global procurement programs. Designed for manufacturers, distributors, healthcare systems, and government agencies, Lathell enables large-scale adoption of very-low-glycemic metabolic nutrition solutions worldwide.
Lathell Nutraceuticals operates a Nevada-based production and export platform supporting international bulk supply and technology partnerships. Through the B2B division, organizations gain access to SAFE SUGAR™ ingredient supply, nutraceutical manufacturing capabilities, and metabolic health technology integration for food, beverage, healthcare, and public nutrition applications.
Procurement-ready engagement, structured documentation posture, and clear pathways for distributors, manufacturers, and institutions to activate supply, licensing, or long-term partnership structures.
Choose the engagement model that fits your organization. Lathell supports scale pathways from supply to integration and long-term partnership structures.
Institutional-scale SAFE SUGAR™ supply for food and beverage manufacturers, healthcare nutrition providers, and government programs requiring very-low-glycemic sugar replacement.
Production of metabolic and specialty nutraceutical formulations under partner branding, supported by Lathell’s Nevada manufacturing and quality systems.
Licensing access to Lathell metabolic nutrition formulations and ingredient technologies for regional manufacturing, product integration, and regulated market deployment.
Structured supply programs for hospitals, ministries of health, national nutrition initiatives, and public health agencies addressing sugar-related disease.
Regional distribution agreements for SAFE SUGAR™ and Lathell nutraceutical technologies across international healthcare and nutrition markets.
Technical guidance for integrating SAFE SUGAR™ into food, beverage, and clinical nutrition production systems at industrial scale.
SAFE SUGAR™ is positioned as a medical-grade, very-low-glycemic sugar replacement ingredient suitable for food manufacturing, clinical nutrition, diabetic dietary programs, and institutional health systems. The B2B platform supports integration across consumer products, hospital nutrition, pharmaceutical-aligned nutrition pathways, and public health food supply chains.
Manufacturer integration for packaged foods and beverages • hospital nutrition and clinical food service • government nutrition programs • public-sector procurement frameworks • distributor-led regional expansion.
All B2B supply and partnership programs are anchored by the Lathell Nutraceuticals Nevada Campus in Clark County—serving as global headquarters, manufacturing center, and export hub. The campus supports bulk production, formulation development, packaging, and worldwide distribution infrastructure.
Institutional-ready production posture • export staging and distribution • documentation and partner onboarding • scalable capacity for global procurement demand.
Lathell B2B serves food and beverage manufacturers, nutraceutical brands, healthcare providers, distributors, governments, and institutional nutrition programs seeking next-generation metabolic nutrition technologies and very-low-glycemic ingredient solutions.
Manufacturers • distributors/importers • hospital systems • ministries of health • national nutrition authorities • institutional procurement bodies • corporate and industrial food integration partners.
For SAFE SUGAR™ supply, licensing, private label manufacturing, distribution agreements, or institutional procurement engagement, contact the Lathell B2B division.
B2B Inquiry
